To map or not to map the cN0 neck: Impact of sentinel lymph node biopsy in canine head and neck tumours. (29th April 2021)

• Record Type: Journal Article
• Authors: Chiti, Lavinia E.; Stefanello, Damiano; Manfredi, Martina; Zani, Davide D.; De Zani, Donatella; Boracchi, Patrizia; Giudice, Chiara; Grieco, Valeria; Di Giancamillo, Mauro; Ferrari, Roberta
• Other Names: Selmic Laura guestEditor.; Culp William guestEditor.
• Is Part Of: Veterinary and comparative oncology. Volume 19:Number 4(2021)
• Page Start: 661
• Page End: 670
• Publication Date: 2021-04-29
• Subjects: dog -- maxillofacial surgery -- oral tumours -- sentinel lymph node -- staging; Veterinary oncology -- Periodicals; Neoplasms -- veterinary -- Periodicals; 636.0896994005
• DOI: 10.1111/vco.12697
• Languages: English
• ISSNs: 1476-5810

Abstract

Abstract: Tumour stage is a prognostic indicator for canine malignant head and neck tumours (MHNT). However, consensus is lacking on nodal staging in the absence of clinically apparent nodal disease (cN0 neck). This prospective observational study aims to determine the diagnostic accuracy of radiopharmaceutical and blue dye for sentinel lymph node biopsy (SLNB), to assess the correspondence between sentinel lymph node (SLN) and clinically expected regional lymph node (RLN) and the impact on staging of the procedure in dogs with MHNT and cN0 neck. Twenty‐three dogs with MHNT and cN0 neck underwent tumour excision and SLNB guided by preoperative lymphoscintigraphy and intraoperative gamma‐probe and blue dye. Diagnostic performances and detection rate were calculated. Correspondence between SLN and RLN, number of nodes excised, histopathological status of the SLN and complications related to the procedure were recorded. The mapping technique identified at least one SLN in 19/23 dogs, with a detection rate of 83%. The SLN did not correspond to the RLN in 52% of dogs. Multiple nodes were removed in 61% of dogs. At histopathology, eight (42%) dogs had SLN+, of which four differed from the RLN. Only minor self‐limiting complications occurred in five (22%) dogs. Radiopharmaceutical and blue dye guidance is accurate (sensitivity 88.9%; specificity 100%) for SLNB in dogs with MHNT and cN0 and allowed the extirpation of unpredictable and/or multiple SLN with minimal morbidity. Incorporation of SLNB in the management of MHNT is desirable to correctly stage the cN0 neck, owing the unpredictability of the lymphatic drainage.